You're mistaken.
MAPS main goal with MDMA assisted psychotherapy involves the legal distribution of MDMA with any profits funding future research too.
https://www.maps.org/maps-media/med...onduct-research-and-sell-mdma-by-prescription
MAPS research occurs in many countries on several continents.
https://www.maps.org/index.php?option=com_content&view=category&id=105&Itemid=584
They perform studies in several countries, but they are entirely focused on the American FDA. Which is fine. After all most pharmaceutical control governmental agencies are the FDA little puppies
In order to distribute, MAPS has to get rid of the FDA scheduling (at least move it to 2) and then it will still be only medical purposes. But in order to do that you need more research, and for that distribution is a problem. EmmaSofia is quite clear about distribution for ALL LEGAL purposes. it's possible in Norway!